4/A
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-25-005496
Options or other derivatives
- Chief Operating Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Morgen Eric Chief Operating Officer | 2025-02-18 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | I | ||
Loading xslF345X05/form4a-02252025_090206.xml…